The genetics of multiple sclerosis

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Compston, Alastair ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Candidates; Genetics; Genome search; Multiple sclerosis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

CLINICAL TRIAL; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GENE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETICS; GENOME; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 0034038721     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Bennets BH, Teutsch SM, Buhler MM et al (1997). The CCR5 deletion mutation fails to protect against multiple sclerosis. Human Immunol 58: 52-59.
2. Carton H, Vlietinck R, Debruyne J et al (1997). Recurrence risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 62: 329-333.
3. Chataway J, Feakes R, Coraddu F et al (1998). The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 121: 1869-1887.
4. Compston DAS, Ebers GC, Lassmann H, McDonald WI, Matthews WB, Wekerle H (1998). McAlpine's Multiple Sclerosis. 3rd edn. Compston DAS (ed), WB Saunders: London, pp. 592.
5. Coraddu F, Reyes-Yanez MP, Aladro Y et al (1998). HLA associations with multiple sclerosis in the Canary Islands. J Neiroimmunol 87: 130-135.
6. Coraddu F, Sawcer S, Feakes R et al (1999). HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 2: 24-33.
7. D'Alfonso S, Nistico L, Zavattari P et al (1999). A linkage analysis of multiple sclerosis with candidate region markers in Sardinian and continental Italian families. Eur J Human Genet 7: 377-385.
8. De La Concha EG, Arroyo R, Crusius JB et al (1997). Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 80: 172-178.
9. Droogan AG, Kirk CW, Hawkins SA et al (1996). T cell receptor alpha, beta, gamma and delta chain microsatellites show no association with multiple sclerosis. Neurology 47: 1049-1053.
10. Ebers GC, Sadovnick AD, Risch NJ (1995). A genetic basis for familial aggregation in multiple sclerosis. Nature 377: 150-151.
11. Ebers GC, Kukay K, Bulman D et al (1996). A full genome search in multiple sclerosis. Nature Genet 13: 472-476.
12. French Research Group on Multiple Sclerosis (1992). Multiple Sclerosis in 54 twinships: concordance rate is independent of zygosity. Ann Neurol 32: 724-727.
13. Harding AE, Sweeney MG, Brockington M et al (1992). Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 115: 989.
14. He B, Yang B, Lundahl J et al (1998a). The myelin basic protein gene in multiple sclerosis: identification of discrete alleles of a 1.3 kb tetranucleotide repeat sequence. Acta Neurologica Scandinavica 97: 46-51.
15. He B, Xu C, Yang B, Landtblom A-M, Fredrikson S, Hillert J (1998b). Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J Neuroimmunol 86: 13-19.
16. Kalman B, Lublin FD, Alder H (1995). Mitochondrial DNA mutations in multiple sclerosis. Multiple Sclerosis 1: 32-36.
17. Kellar Wood H, Robertson N, Govan GG et al (1994). Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 36: 109-112.
18. Kuokkanen S, Gschwend M, Rioux JD et al (1997). Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Human Genet 61: 1379-1387.
19. La Mantia L, Illeni MT, Milanese C et al (1990). HLA and multiple sclerosis in Italy: a review of the literature. J Neurol 237: 441-444.
20. Ligers A, He B, Fogdell-Hahn A, Olerup O, Hillert J (1997). No linkage or association of a VNTR marker in the junction region of the immunoglobulin heavy chain genes in multiple sclerosis. Eur J Immunogenet 24: 259-264.
21. Marrosu MG, Muntoni F, Murru MR et al (1992). HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1.0201 and DQB1.0302 alleles. Neurology 42: 883-886.
22. Multiple Sclerosis Genetics Group (1996). A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 13: 469-471.
23. Mumford CJ, Wood NW, Kellar-Wood HF et al (1994). The British Isles survey of multiple sclerosis in twins. Neurology 44: 11-15.
24. Mycko MP, Kwinkowoski M, Tronczynska E et al (1998). Multiple sclerosis: increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 44: 70-75.
25. Nellemann LJ, Frederiksen J, Morling N (1995). PCR typing of two short tandem repeat (STR) structures upstream of the human myelin basic protein (MBP) gene; genetic susceptibility in multiple sclerosis and monosymptomatic idiopathic optic neuritis in Danes. Multiple Sclerosis 1: 186-189.
26. Nishimura M, Obayashi H, Ohta M et al (1995). No association of the 11778 mitochondrial mutation and multiple sclerosis in Japan. Neurology 45: 1333-1334.
27. Olerup O, Hillert J (1991). HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38: 1-15.
28. Price SE, Sharpe G, Boots A et al (1997). Role of myelin basic protein and proteolipid protein genes in multiple sclerosis: single strand conformation polymorphism analysis of the human sequences. Neuropathol Applied Neurobiol 23: 457-467.
29. Reboul J, Mertens C, Levillayer F et al (2000). Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. J Neuroimmunol 102: 107-112.
30. Riordan Eva P, Sanders MD, Govan GG et al (1995). The clinical features of Leber's hereditary optic neuropathy defined by the presence of pathogenic mitochondrial DNA mutation. Brain 118: 319-337.
31. Risch N (1990). Linkage strategies for genetically complex traits. Am J Human Genet 46: 222-253.
32. Robertson NP, Fraser M, Deans J, Clayton D, Compston DAS (1996). Age adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 119: 449-455.
33. Robertson NP, O'Riordan JI, Chataway J et al (1997). Clinical characteristics and offspring recurrence rates of conjugal multiple sclerosis. Lancet 349: 1587-1590.
34. Rodriguez D, Della Gaspera B, Zalc B et al (1997). Identification of a Val 145 Ile substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. Multiple Sclerosis 3: 377-382.
35. Sadovnick AD, Baird PA, Ward RH (1988). Multiple sclerosis; updated risks for relatives. Am J Medical Genet 29: 533-541.
36. Sadovnick AD, Armstrong H, Rice GPA et al (1993). A population-based study of multiple sclerosis in twins: update. Ann Neurol 33: 281-285.
37. Sadovnick AD, Ebers GC, Dyment DA, Risch N, the Canadian Collaborative Study Group (1996). Evidence for genetic basis of multiple sclerosis. Lancet 347: 1728-1730.
38. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B et al (1997). HLA-DR and -DQ associations with multiple sclerosis in Turkey. Human Immunol 55: 59-65.
39. Sawcer S, Jones HB, Feakes R et al (1996). A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 13: 464-468.
40. Thompson RJ, Mason CR, Douglas AJ et al (1996). Analysis of polymorphisms of the 2′3′-cyclic nucleotide-3′-phosphodiesterase gene in patients with multiple sclerosis. Multiple Sclerosis 2: 215-221.
41. Tienari P, Wikstrom J, Sajantila A, Palo J, Peltonen L (1992). Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 340: 987-991.
42. Tienari P, Kuokkanen S, Pastinen T et al (1998). Golli-MBP gene in multiple sclerosis. J Neuroimmunol 81: 158-167.
43. Vanderbroeck K, Martino G, Marrosu M et al (1997). Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol 76: 189-192.
44. Wansen K, Pastinen T, Kuokkanen S, Wokstrom J et al (1997). Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR-β, IgH, IFN-gamma and IL-12ra/IL-1β loci. J Neurol 79: 29-36.
45. Xu C, Dai Y, Fredrikson S, Hillert J (1999). Association and linkage analysis of candidate chromosomal regions in multiple sclerosis: indication of disease genes in 12q23. Eur J Human Genet 7: 110-116.